Total Payments
$5,039
2024 Payments
$396.38
Companies
46
Transactions
364
Medicare Patients
5,544
Medicare Billing
$435,752
Payment Breakdown by Category
Food & Beverage$4,880 (96.8%)
Gifts$67.68 (1.3%)
Education$66.39 (1.3%)
Other$24.98 (0.5%)
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Food and Beverage | $4,880 | 356 | 96.8% |
| Gift | $67.68 | 1 | 1.3% |
| Education | $66.39 | 5 | 1.3% |
| Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program | $24.98 | 2 | 0.5% |
Top Paying Companies
| Company | Total | Records | Latest Year |
|---|---|---|---|
| Amgen Inc. | $524.56 | 31 | $0 (2024) |
| ABBVIE INC. | $508.04 | 32 | $0 (2024) |
| Novo Nordisk Inc | $488.66 | 39 | $0 (2024) |
| Lilly USA, LLC | $415.17 | 36 | $0 (2023) |
| Supernus Pharmaceuticals, Inc. | $268.51 | 29 | $0 (2018) |
| PFIZER INC. | $266.52 | 19 | $0 (2024) |
| GlaxoSmithKline, LLC. | $264.82 | 17 | $0 (2024) |
| Merck Sharp & Dohme LLC | $263.69 | 21 | $0 (2022) |
| AstraZeneca Pharmaceuticals LP | $255.28 | 19 | $0 (2024) |
| Janssen Pharmaceuticals, Inc | $253.27 | 19 | $0 (2023) |
Payment History by Year
| Year | Amount | Transactions | Top Company |
|---|---|---|---|
| 2024 | $396.38 | 19 | ABBVIE INC. ($87.79) |
| 2023 | $728.08 | 48 | ABBVIE INC. ($133.94) |
| 2022 | $606.65 | 39 | ABBVIE INC. ($137.24) |
| 2021 | $603.35 | 45 | AbbVie Inc. ($149.07) |
| 2020 | $321.05 | 23 | Novo Nordisk Inc ($60.28) |
| 2019 | $553.35 | 46 | Lilly USA, LLC ($108.45) |
| 2018 | $906.44 | 73 | Supernus Pharmaceuticals, Inc. ($135.95) |
| 2017 | $923.66 | 71 | Novo Nordisk Inc ($147.27) |
All Payment Transactions
364 individual payment records from CMS Open Payments — Page 1 of 15
| Date | Company | Product | Nature | Form | Amount | Type |
|---|---|---|---|---|---|---|
| 10/07/2024 | Phathom Pharmaceuticals, Inc. | VOQUEZNA (Drug) | Food and Beverage | In-kind items and services | $15.19 | General |
| Category: GASTROENTEROLOGY | ||||||
| 09/23/2024 | Amgen Inc. | EVENITY (Biological), Prolia | Food and Beverage | In-kind items and services | $23.08 | General |
| Category: Bone Health | ||||||
| 09/19/2024 | PFIZER INC. | PREVNAR 20 (Biological), COMIRNATY, ABRYSVO | Food and Beverage | In-kind items and services | $20.45 | General |
| Category: VACCINES | ||||||
| 09/18/2024 | ABBVIE INC. | CREON (Drug), LINZESS | Food and Beverage | In-kind items and services | $19.29 | General |
| Category: ENDOCRINOLOGY | ||||||
| 09/10/2024 | ABBVIE INC. | VRAYLAR (Drug) | Food and Beverage | In-kind items and services | $23.07 | General |
| Category: NEUROSCIENCE | ||||||
| 09/04/2024 | AstraZeneca Pharmaceuticals LP | BREZTRI (Drug) | Food and Beverage | In-kind items and services | $15.72 | General |
| Category: Respiratory | ||||||
| 08/07/2024 | Novo Nordisk Inc | — | Food and Beverage | In-kind items and services | $28.67 | General |
| 08/01/2024 | Sumitomo Pharma America, Inc. | GEMTESA (Drug) | Food and Beverage | In-kind items and services | $24.33 | General |
| Category: UROLOGY | ||||||
| 07/25/2024 | Corcept Therapeutics | Korlym (Drug) | Food and Beverage | In-kind items and services | $25.66 | General |
| Category: Endocrinology | ||||||
| 07/16/2024 | IDORSIA PHARMACEUTICALS US INC | QUVIVIQ (Drug) | Food and Beverage | In-kind items and services | $15.16 | General |
| Category: Insomnia | ||||||
| 06/20/2024 | Corcept Therapeutics | Korlym (Drug) | Food and Beverage | In-kind items and services | $19.69 | General |
| Category: Endocrinology | ||||||
| 06/11/2024 | Amgen Inc. | EVENITY (Biological), Prolia | Food and Beverage | In-kind items and services | $25.58 | General |
| Category: Bone Health | ||||||
| 06/05/2024 | Amgen Inc. | Otezla (Drug), Repatha | Food and Beverage | In-kind items and services | $14.13 | General |
| Category: Inflammation | ||||||
| 03/25/2024 | ABBVIE INC. | VRAYLAR (Drug) | Food and Beverage | In-kind items and services | $24.43 | General |
| Category: NEUROSCIENCE | ||||||
| 03/20/2024 | GlaxoSmithKline, LLC. | BEXSERO (Biological), PEDIARIX, ROTARIX | Food and Beverage | In-kind items and services | $13.18 | General |
| Category: VACCINES | ||||||
| 03/13/2024 | Sumitomo Pharma America, Inc. | GEMTESA (Drug) | Food and Beverage | In-kind items and services | $19.62 | General |
| Category: UROLOGY | ||||||
| 02/28/2024 | Novartis Pharmaceuticals Corporation | LEQVIO (Drug) | Food and Beverage | In-kind items and services | $23.30 | General |
| Category: Cardiology/Vascular Diseases | ||||||
| 01/29/2024 | Amgen Inc. | Repatha (Biological) | Food and Beverage | In-kind items and services | $24.83 | General |
| Category: Cardiology | ||||||
| 01/17/2024 | ABBVIE INC. | VRAYLAR (Drug) | Food and Beverage | In-kind items and services | $21.00 | General |
| Category: NEUROSCIENCE | ||||||
| 12/20/2023 | AstraZeneca Pharmaceuticals LP | FARXIGA (Drug) | Food and Beverage | In-kind items and services | $16.66 | General |
| Category: Cardiovascular and Metabolism | ||||||
| 12/13/2023 | PFIZER INC. | ELIQUIS (Drug), PAXLOVID, NURTEC ODT | Food and Beverage | In-kind items and services | $13.62 | General |
| Category: CARDIOVASCULAR;METABOLIC DISEASE | ||||||
| 12/04/2023 | Lilly USA, LLC | MOUNJARO (Drug) | Food and Beverage | In-kind items and services | $15.02 | General |
| Category: Diabetes | ||||||
| 11/27/2023 | Amgen Inc. | Otezla (Drug), Repatha | Food and Beverage | In-kind items and services | $16.75 | General |
| Category: Inflammation | ||||||
| 10/17/2023 | Amgen Inc. | EVENITY (Biological), Prolia | Food and Beverage | In-kind items and services | $15.93 | General |
| Category: Bone Health | ||||||
| 10/12/2023 | Lilly USA, LLC | MOUNJARO (Drug) | Food and Beverage | In-kind items and services | $13.07 | General |
| Category: Diabetes | ||||||
Medicare Billing by Year
| Year | Procedures | Beneficiaries | Services | Submitted | Medicare Paid |
|---|---|---|---|---|---|
| 2023 | 30 | 1,454 | 4,245 | $279,539 | $138,841 |
| 2022 | 23 | 1,340 | 3,031 | $217,045 | $95,416 |
| 2021 | 23 | 1,397 | 2,831 | $233,651 | $109,410 |
| 2020 | 21 | 1,353 | 2,865 | $229,479 | $92,086 |
Total Patients
5,544
Total Services
12,972
Medicare Billing
$435,752
Procedure Codes
97
All Medicare Procedures & Services
97 procedure records from CMS Medicare Utilization — Page 1 of 4
| HCPCS | Description | Setting | Year | Patients | Services | Charges | Medicare Paid | Ratio |
|---|---|---|---|---|---|---|---|---|
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2023 | 199 | 584 | $98,815 | $47,586 | 48.2% |
| J0897 | Injection, denosumab, 1 mg | Office | 2023 | 19 | 1,500 | $34,500 | $25,636 | 74.3% |
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2023 | 145 | 286 | $41,074 | $16,368 | 39.9% |
| G0439 | Annual wellness visit, includes a personalized prevention plan of service (pps), subsequent visit | Office | 2023 | 123 | 123 | $21,525 | $14,900 | 69.2% |
| 90677 | Pneumococcal conjugate vaccine, 20 valent (pcv20), for intramuscular use | Office | 2023 | 26 | 26 | $7,800 | $7,350 | 94.2% |
| 36415 | Insertion of needle into vein for collection of blood sample | Office | 2023 | 188 | 489 | $8,802 | $4,059 | 46.1% |
| 99215 | Established patient office or other outpatient visit, 40-54 minutes | Office | 2023 | 25 | 25 | $5,550 | $2,626 | 47.3% |
| 90662 | Influenza vaccine split virus, preservative free | Office | 2023 | 29 | 30 | $3,000 | $2,059 | 68.6% |
| 99495 | Transitional care management services for problem of at least moderate complexity | Office | 2023 | 11 | 12 | $3,948 | $1,829 | 46.3% |
| 20610 | Aspiration and/or injection of fluid from large joint | Office | 2023 | 32 | 46 | $9,568 | $1,759 | 18.4% |
| G0438 | Annual wellness visit; includes a personalized prevention plan of service (pps), initial visit | Office | 2023 | 12 | 12 | $2,220 | $1,740 | 78.4% |
| 17000 | Destruction of precancer skin growth, 1 growth | Office | 2023 | 40 | 49 | $6,174 | $1,658 | 26.9% |
| 0241U | Respiratory infectious agent detection by rna for severe acute respiratory syndrome coronavirus 2 (covid 19), influenza a, influenza b, and respiratory syncytial virus, upper respiratory specimen, each reported as detected or not detected | Office | 2023 | 11 | 11 | $1,925 | $1,538 | 79.9% |
| 96372 | Injection of drug or substance under skin or into muscle | Office | 2023 | 49 | 130 | $5,460 | $1,264 | 23.1% |
| G0444 | Annual depression screening, 5 to 15 minutes | Office | 2023 | 71 | 71 | $1,775 | $1,218 | 68.6% |
| 17110 | Destruction of skin growth, 1-14 growths | Office | 2023 | 14 | 14 | $2,800 | $1,092 | 39.0% |
| 71046 | X-ray of chest, 2 views | Office | 2023 | 45 | 64 | $2,688 | $926.14 | 34.5% |
| J1030 | Injection, methylprednisolone acetate, 40 mg | Office | 2023 | 53 | 172 | $3,784 | $916.92 | 24.2% |
| G0008 | Administration of influenza virus vaccine | Office | 2023 | 30 | 31 | $1,147 | $858.00 | 74.8% |
| G0009 | Administration of pneumococcal vaccine | Office | 2023 | 27 | 27 | $675.00 | $661.50 | 98.0% |
| 20552 | Injection of trigger points, 1-2 muscles | Office | 2023 | 15 | 17 | $4,216 | $598.17 | 14.2% |
| 17003 | Destruction of precancer skin growth, 2-14 growths | Office | 2023 | 28 | 110 | $4,180 | $456.67 | 10.9% |
| 87426 | Detection test by immunoassay technique for severe acute respiratory syndrome coronavirus | Office | 2023 | 12 | 13 | $715.00 | $450.06 | 62.9% |
| 81003 | Automated urinalysis test | Office | 2023 | 157 | 203 | $2,639 | $446.60 | 16.9% |
| 72100 | X-ray of lower and sacral spine, 2-3 views | Office | 2023 | 15 | 16 | $720.00 | $268.51 | 37.3% |
About Dr. John Hart, MD
Dr. John Hart, MD is a Family Medicine healthcare provider based in Hesston, Kansas. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 04/05/2006. The National Provider Identifier (NPI) number assigned to this provider is 1689636698.
According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Dr. John Hart, MD has received a total of $5,039 in payments from pharmaceutical and medical device companies, with $396.38 received in 2024. These payments were reported across 364 transactions from 46 companies. The most common payment nature is "Food and Beverage" ($4,880).
As a Medicare-enrolled provider, Hart has provided services to 5,544 Medicare beneficiaries, totaling 12,972 services with total Medicare billing of $435,752. Data is available for 4 years (2020–2023), covering 97 distinct procedure/service records.
Ad
Practice Information
- Specialty Family Medicine
- Location Hesston, KS
- Active Since 04/05/2006
- Last Updated 06/04/2019
- Taxonomy Code 207Q00000X
- Entity Type Individual
- NPI Number 1689636698
Products in Payments
- VRAYLAR (Drug) $290.87
- TROKENDI XR (Drug) $268.51
- XARELTO (Drug) $240.37
- Aimovig (Biological) $176.03
- EVENITY (Biological) $152.93
- TRELEGY ELLIPTA (Drug) $148.26
- TRULICITY (Drug) $146.57
- UBRELVY (Drug) $138.62
- EMGALITY (Drug) $132.67
- Ozempic (Drug) $130.18
- ELIQUIS (Drug) $102.24
- FARXIGA (Drug) $99.15
- Victoza (Drug) $98.71
- Saxenda (Drug) $96.07
- JANUVIA (Drug) $89.81
- JARDIANCE (Drug) $87.79
- MOUNJARO (Drug) $84.45
- BREZTRI (Drug) $78.25
- Repatha (Biological) $78.07
- NURTEC ODT (Drug) $71.33
Explore
Data Sources
Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.